Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000493086 | SCV000582105 | likely pathogenic | not provided | 2019-07-02 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 30990523) |
Baylor Genetics | RCV004568622 | SCV004199803 | likely pathogenic | Mitochondrial trifunctional protein deficiency 1 | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004586739 | SCV005076591 | uncertain significance | not specified | 2024-04-24 | criteria provided, single submitter | clinical testing | Variant summary: HADHB c.686G>A (p.Arg229Gln) results in a conservative amino acid change located in the Thiolase, N-terminal (IPR020616) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251326 control chromosomes (gnomAD). c.686G>A has been reported in the literature in individuals affected with features of Mitochondrial Trifunctional Protein Deficiency (Madsen_2019, Guan_2021). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30990523, 34712195). ClinVar contains an entry for this variant (Variation ID: 429516). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |
Fulgent Genetics, |
RCV005027569 | SCV005655909 | likely pathogenic | Mitochondrial trifunctional protein deficiency 2 | 2024-04-24 | criteria provided, single submitter | clinical testing |